NRAS GENE MUTATION
Clinical trials for NRAS GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new NRAS GENE MUTATION trials appear
Sign up with your email to follow new studies for NRAS GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets 'Undruggable' cancer mutations in major trial
Disease control Recruiting nowThis study is testing a new oral drug, S241656, alone and in combination with other cancer therapies. It aims to find a safe and effective dose for adults with advanced cancers, including lung, pancreatic, and colorectal cancers, that have specific genetic mutations like KRAS or …
Matched conditions: NRAS GENE MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Last-Hope cancer drug offered to desperate patients
Disease control AVAILABLEThis program provides access to an investigational drug called ulixertinib for patients with advanced cancers that have specific genetic changes (MAPK pathway mutations). It is for people who have run out of other treatment options. The drug aims to control the cancer's growth, e…
Matched conditions: NRAS GENE MUTATION
Sponsor: xCures • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC